MPYS||All Specialties | Boehringer Ingelheim Pro

Shorts

Clinical relationship between the heart and the kidneys

Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)

Clinical relationship between the heart and the kidneys

Watch now Opens in new tab

Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes?

Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)

Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes?

Watch now Opens in new tab

How has recent evidence and the ESC 2023 guidelines changed management of heart failure?

Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)

How has recent evidence and the ESC 2023 guidelines changed management of heart failure?

Watch now Opens in new tab

Upcoming Events

Past Events

PRIME Summit 2 : Post event video day 1

02:13:04

PRIME Summit 2 : Post event video day 1

Watch now Opens in new tab

PRIME Summit 2 : Post event video day 2

02:00:53

PRIME Summit 2 : Post event video day 2

Watch now Opens in new tab

Evolving evidence in the role of empagliflozin in kidney diseases

Adrian Liew (Singapore) | Per Henrik Groop (Finland) | Michel Jadoul (Belgium)

Evolving evidence in the role of empagliflozin in kidney diseases

Watch now Opens in new tab

Resources

Patient Materials

Did you find what you were looking for?

Yes

No

Your feedback submitted Successfully !